The relationship between local dose and loss of function for irradiated lung

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 1, 2003, Pages 106-113

  Gopal, Ramesh ^a   Tucker, Susan L ^a   Komaki, Ritsuko ^a   Liao, Zhongxing ^a   Forster, Kenneth M ^a   Stevens, Craig ^a   Kelly, Jason F ^a   Starkschall, George ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Amifostine; Diffusing capacity; Dose response; Pulmonary function; Radiation therapy

Indexed keywords

ALGORITHMS; CHEMOTHERAPY; IRRADIATION; PATIENT TREATMENT; REGRESSION ANALYSIS;

HYPERFRACTIONATED(HF) RADIATION;

PULMONARY DISEASES;

AMIFOSTINE; CARBON MONOXIDE; CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; FEMALE; HISTOGRAM; HUMAN; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TOTAL LUNG CAPACITY; TREATMENT PLANNING;

EID: 0345269968     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00094-4     Document Type: Article

References (39)

1. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res. 104:1985;S13-S19.
2. Lyman J.T., Wolbarst A.B. Optimization of radiation therapy, IV A dose-volume histogram reduction algorithm . Int J Radiat Oncol Biol Phys. 17:1989;433-436.
3. Kutcher G.J., Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation The effective volume method . Int J Radiat Oncol Biol Phys. 16:1989;1623-1630.
4. Cohen L. The tissue volume factor in radiation oncology. Int J Radiat Oncol Biol Phys. 8:1982;1771-1774.
5. Niemierko A., Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol. 20:1991;166-176.
6. Kutcher G.J., Burman C., Brewster L., et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 21:1991;137-146.
7. Abratt R.P., Willcox P.A. The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys. 31:1995;915-919.
8. Marks L.B. The pulmonary effects of thoracic irradiation. Oncology (Huntingt). 8:1994;89-106. ; discussion 100, 103-104.
9. Theuws J.C., Muller S.H., Seppenwoolde Y., et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma A follow-up study . J Clin Oncol. 17:1999;3091-3100.
10. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys. 39:1997;563-570.
11. Robert F., Childs H.A., Spencer S.A., et al. Phase I/IIa study of concurrent paclitaxel, and cisplatin with radiation therapy in locally advanced non-small cell lung cancer. Analysis of early and late pulmonary morbidity. Semin Radiat Oncol. 9:1999;136-147.
12. Fan M., Marks L.B., Hollis D., et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol. 19:2001;543-550.
13. Gopal R., Starkschall G., Tucker S.L., et al. The Effects of radiation therapy, chemotherapy and the radioprotector amifostine on the diffusion capacity of patients with non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 51(S):2001;22.
14. Prato F.S., Kurdyak R., Saibil E.A., et al. Regional and total lung function in patients following pulmonary irradiation. Invest Radiol. 12:1977;224-237.
15. Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys. 38:1997;399-409.
16. Levinson B., Marks L.B., Munley M.T., et al. Regional dose response to pulmonary irradiation using a manual method. Radiother Oncol. 48:1998;53-60.
17. Marks L.B., Sherouse G.W., Munley M.T., et al. Incorporation of functional status into dose-volume analysis. Med Phys. 26:1999;196-199.
18. Theuws J.C., Kwa S.L., Wagenaar A.C., et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma, and breast cancer. Radiother Oncol. 48:1998;33-43.
19. Theuws J.C., Seppenwoolde Y., Kwa S.L., et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys. 47:2000;1201-1208.
20. Seppenwoolde Y., Muller S.H., Theuws J.C., et al. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 47:2000;681-690.
21. Theuws J.C., Kwa S.L., Wagenaar A.C., et al. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol. 49:1998;233-243.
22. Boersma L.J., Damen E.M., de Boer R.W., et al. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol. 14:1996;1431-1441.
23. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). [Editorial] Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
24. Ferguson M.K., Reeder L.B., Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 109:1995;275-281. ; discussion 281-273.
25. Abratt R.P., Willcox P.A., Smith J.A. Lung cancer in patients with borderline lung functions - zonal lung perfusion scans at presentation and lung function after high dose irradiation. Radiother Oncol. 19:1990;317-322.
26. Susskind H., Acevedo J.C., Iwai J., et al. Heterogeneous ventilation and perfusion A sensitive indicator of lung impairment in nonsmoking coal miners . Eur Respir J. 1:1988;232-241.
27. Marks L.B., Hollis D., Munley M., et al. The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests. Cancer. 88:2000;2135-2141.
28. Geara F.B., Komaki R., Tucker S.L., et al. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung Evidence for inherent interindividual variation . Int J Radiat Oncol Biol Phys. 41:1998;279-286.
29. Boersma L.J., Damen E.M., de Boer R.W., et al. Estimation of overall pulmonary function after irradiation using dose- effect relations for local functional injury. Radiother Oncol. 36:1995;15-23.
30. Fan M., Marks L.B., Lind P., et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys. 51:2001;311-317.
31. Lyman J.T., Wolbarst A.B. Optimization of radiation therapy, III A method of assessing complication probabilities from dose-volume histograms . Int J Radiat Oncol Biol Phys. 13:1987;103-109.
32. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 45:1999;323-329.
33. Capizzi R.L. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Semin Oncol. 26:1999;3-21.
34. Down J.D., Laurent G.J., McAnulty R.J., et al. Oxygen-dependent protection of radiation lung damage in mice by WR 2721. Int J Radiat Biol. 46:1984;597-607.
35. Antonadou D., Coliarakis N., Synodinou M., et al. Randomized phase III trial of radiation treatment+/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys. 51:2001;915-922.
36. Gridelli C., Guida C., Barletta E., et al. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer A phase I study . Lung Cancer. 29:2000;131-137.
37. Tucker S.L., Liao Z.X., Travis E.L. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys. 38:1997;1055-1066.
38. Liao Z.X., Travis E.L., Tucker S.L. Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys. 32:1995;1359-1370.
39. Marks L.B., Spencer D.P., Sherouse G.W., et al. The role of three dimensional functional lung imaging in radiation treatment planning the functional dose-volume histogram . Int J Radiat Oncol Biol Phys. 33:1995;65-75.